Natural Course and Prognosis of Hospitalized Patients With Cirrhosis
Launched by KANGBUK SAMSUNG HOSPITAL · Jan 6, 2022
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how liver cirrhosis affects hospitalized patients and what their future health may look like. The researchers want to understand the natural progression of this condition and how different complications, like fluid build-up, bleeding, or infections, impact patients while they are in the hospital.
To be eligible for the study, patients need to be hospitalized due to complications related to liver cirrhosis. This means they might have issues like severe fluid retention, confusion, or kidney problems that are linked to their liver disease. The study welcomes all adults, regardless of gender, and is currently looking for participants. If you or a loved one qualifies and chooses to join, you will be monitored throughout your hospital stay and may have follow-up appointments afterward to help the researchers gather important information about your health journey.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hospitalized patients with liver cirrhosis
- • Admission to the hospital because of cirrhotic complications such as uncontrolled ascites, variceal bleeding, hepatic encephalopathy, hepatorenal syndrome, spontaneous bacterial peritonitis, hepatocellular carcinoma, acute kidney injury, bacterial infection, acute liver failure, and etc.
- Exclusion Criteria:
- • Admission to the hospital without cirrhotic complications
- • Patients who refuse the follow-up of outpatient department
About Kangbuk Samsung Hospital
Kangbuk Samsung Hospital is a leading healthcare institution in South Korea, renowned for its commitment to advanced medical research and clinical excellence. As a sponsor of clinical trials, the hospital integrates cutting-edge technology and innovative therapies to enhance patient care and outcomes. With a multidisciplinary team of experienced researchers and healthcare professionals, Kangbuk Samsung Hospital is dedicated to conducting rigorous clinical studies that adhere to the highest ethical standards. Its focus on translational medicine aims to bridge the gap between laboratory findings and clinical applications, ultimately contributing to the advancement of medical science and improving therapeutic options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Hwaseong Si, Gyeonggi, Korea, Republic Of
Kwangju, , Korea, Republic Of
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Won Sohn, MD, PhD
Principal Investigator
Kangbuk Samsung Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials